JOURNAL OF THE AMEIUCAN PHARMACEUTICAL ASSOCIATION
MONTHLY DRUG INDEX
N NB • • • . • • • • • • • • • • . . • . frolD p . 107 I-cc. vials each packaged with six 0.9-cc. vials of 0.5 % procaine hydrochloride in isotonic sodium chloride solution. Preserved with chlorobutanol 0.4% as a sterile diluent.
• ISOPENTAQUINE GENERIC NAME FOR (8-[4-ISOPROPYLAMINO-I-METHYL BUTYLAMINO]-6-METHOXYQUINOLINE) The Council was requested by the Malaria Study Section of the U. S. Public Health Service to consider recognition of the generic term isopentaquine for the antimalarial compound known as Sn 13,274 (8-[4isopropyl amino - 1 - methylbutylamino] - 6 - methoxyquinoline). As a result of its deliberation, the Council voted to recognize the stated generic term. The Council calls attention to the fact that the drug will be available only as the oxalate salt, which should be designated as isopentaquine oxalate. In view of the fact that t he base content of the salt is more uniform than t he oxalate content, the labeling for any marketed product should bear a statement such as "Each tablet corresponds to ........... . isopentaquine base."
PEC TIN H.F.
FOR MEDICINAL AND PHARMACEUTICAL USES
• MA D E FROM OUR OWN CALIFORNIA CITRUS FRUITS
• WIRE OR WRITE FOR P RIC E SAN DIN FO RM A'T1 0 N
CALIFO RNIA FRUIT GR OWERS EXCH ANGE Products Department, Ontario, Calif.
Conven t ion Hotel R eser v a tions There will be plenty of room at Jacksonville for all members of the ASSOCIATION who wish to attend the Convention. All hotel reservations must be made through the A. PH. A. Housing Committee. Jacksonville Tourist and Convention Bureau, 307 Hogan Street, Jacksonville 2, Fla. Every member of the AsSOCIATION will receive a hotel reservation form similar to the one reproduced on page 113 of this issue. Additional forms may be obtained by writing to t.he ASSOCIATION office.